Mobia Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	51.89	32.04	15.64
Revenue Growth	-	104.81%	-
Cost of Revenue	9.05	6.07	3.19
Gross Profit	42.84	25.98	12.45
Selling, General & Admin	101.93	65.83	32.44
Research & Development	8.66	6.52	4.24
Operating Expenses	110.58	72.34	36.69
Operating Income	-67.74	-46.37	-24.24
Interest Expense	-1.11	-0.97	-0.97
Other Non Operating Income (Expenses)	-1.2	0.84	0.62
Pretax Income	-70.05	-46.49	-24.59
Income Tax Expense	0.01	0.01	0.01
Net Income	-70.06	-46.5	-24.6
Net Income to Common	-70.06	-46.5	-24.6
Net Income Growth	-	-	-
Shares Outstanding (Basic)	15	2	2
Shares Outstanding (Diluted)	15	2	2
Shares Change	-	12.54%	-
EPS (Basic)	-4.66	-20.64	-12.29
EPS (Diluted)	-4.66	-20.64	-12.29
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-61.45	-46.06	-24.36
Free Cash Flow Per Share	-4.09	-20.45	-12.17
Gross Margin	82.56%	81.07%	79.59%
Operating Margin	-130.55%	-144.71%	-154.92%
Profit Margin	-135.02%	-145.12%	-157.26%
Free Cash Flow Margin	-118.42%	-143.75%	-155.69%
EBITDA	-67.32	-46.22	-24.12
EBITDA Margin	-129.75%	-144.24%	-154.18%
D&A For EBITDA	0.42	0.15	0.12
EBIT	-67.74	-46.37	-24.24
EBIT Margin	-130.55%	-144.71%	-154.92%
Advertising Expenses	-	3.44	1.32

SEC Filings: 10-K · 10-Q